5AM Venture Management, LLC Long-Term Concentrated

Location: San Francisco, CA

CIK: 0001799883 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value: $419M (100.0% shares, 0.0% debt)

Holdings (31)

TRDA ENTRADA THERAPEUTICS INC 18.2%
Value $76.22M Shares 4,408,379 Est. Cost $17.12 Unrealized
ELVN ENLIVEN THERAPEUTICS INC 8.8%
Value $36.67M Shares 1,629,765 Est. Cost $20.34 Unrealized +27.5%
SKYE SKYE BIOSCIENCE INC 6.7%
Value $28.05M Shares 9,913,168 Est. Cost $11.84 Unrealized -64.7%
TECX TECTONIC THERAPEUTIC INC 6.6%
Value $27.55M Shares 596,660 Est. Cost $15.77 Unrealized +168.1%
ARTV ARTIVA BIOTHERAPEUTICS INC 5.7%
Value $23.72M Shares 2,353,304 Est. Cost $11.59 Unrealized +3.6%
DNTH DIANTHUS THERAPEUTICS INC 5.3%
Value $22.4M Shares 1,027,711 Est. Cost $12.62 Unrealized +103.8%
BHVN BIOHAVEN LTD 4.3%
Value $17.89M Shares 478,972 Est. Cost $33.89 Unrealized +37.7%
PHVS PHARVARIS N V 3.6%
Value $15.29M Shares 797,600 Est. Cost $19.05 Unrealized +8.1%
MLTX MOONLAKE IMMUNOTHERAPEUTICS 3.6%
Value $15.29M Shares 282,313 Est. Cost $25.81 Unrealized +97.8%
CAMP CAMP4 THERAPEUTICS CORP 3.6%
Value $15.28M Shares 2,927,915 Est. Cost $8.22 Unrealized 0.0%
VRDN VIRIDIAN THERAPEUTICS INC 3.4%
Value $14.12M Shares 736,595 Est. Cost $17.93 Unrealized +21.2%
CNTA CENTESSA PHARMACEUTICALS PLC 3.3%
Value $13.92M Shares 830,945 Est. Cost $11.45 Unrealized
ERAS ERASCA INC 3.2%
Value $13.57M Shares 5,405,404 Est. Cost $2.16 Unrealized +27.1%
PRAX PRAXIS PRECISION MEDICINES I 3.1%
Value $13.08M Shares 170,000 Est. Cost $44.86 Unrealized +61.3%
TYRA TYRA BIOSCIENCES INC 3.1%
Value $13.06M Shares 939,298 Est. Cost $15.18 Unrealized +19.5%
CLDX CELLDEX THERAPEUTICS INC NEW 3.0%
Value $12.57M Shares 497,270 Est. Cost $32.09 Unrealized -15.3%
EYPT EYEPOINT PHARMACEUTICALS INC 1.9%
Value $7.822M Shares 1,050,000 Est. Cost $9.03 Unrealized +3.1%
VKTX VIKING THERAPEUTICS INC 1.8%
Value $7.629M Shares 189,593 Est. Cost $14.60 Unrealized +290.7%
VOR BIOPHARMA INC 1.7%
Value $7.062M Shares 6,361,723 Est. Cost $43.10 Unrealized
ANAB ANAPTYSBIO INC 1.1%
Value $4.736M Shares 357,733 Est. Cost $28.24 Unrealized -14.2%
AKERO THERAPEUTICS INC 1.1%
Value $4.59M Shares 165,000 Est. Cost $27.82 Unrealized
SCPHARMACEUTICALS INC 1.0%
Value $4.25M Shares 1,200,647 Est. Cost $5.92 Unrealized
TARA PROTARA THERAPEUTICS INC 1.0%
Value $4.224M Shares 800,000 Est. Cost $3.23 Unrealized 0.0%
GHRS GH RESEARCH PLC 1.0%
Value $4.009M Shares 572,665 Est. Cost $10.15 Unrealized -20.8%
RALLYBIO CORP 0.8%
Value $3.485M Shares 3,630,724 Est. Cost $17.58 Unrealized
SLN SILENCE THERAPEUTICS PLC 0.8%
Value $3.276M Shares 476,200 Est. Cost $21.60 Unrealized
ADVERUM BIOTECHNOLOGIES INC 0.6%
Value $2.53M Shares 541,666 Est. Cost $14.14 Unrealized
ALEC ALECTOR INC 0.4%
Value $1.882M Shares 995,841 Est. Cost $3.76 Unrealized 0.0%
MERSANA THERAPEUTICS INC 0.4%
Value $1.866M Shares 1,305,000 Est. Cost $4.03 Unrealized
CIDARA THERAPEUTICS INC 0.4%
Value $1.525M Shares 56,725 Est. Cost $11.94 Unrealized
ZNTL ZENTALIS PHARMACEUTICALS INC 0.4%
Value $1.485M Shares 490,000 Est. Cost $23.99 Unrealized -86.3%